Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1

Phase 3

Completed

• Conditions: Opioid-Related Disorders

• Registration Number: NCT00078117
• Lead Sponsor: University of California, Los Angeles

Brief Summary

The purpose of this protocol is to to compare the clinical utility of two dosage tapering regimens in Buprenorphine/Naloxone stabilized subjects for opiate detoxification.

Detailed Description

Not available

Study Timeline

• Study Start: 2003-06
• Study First Submitted: 2004-02-19
• Study First Submitted QC: 2004-02-19
• Study First Posted: 2004-02-20
• Primary Completion: 2005-05
• Study Completion: 2005-05
• Status Verified: 2010-04
• Last Update Submitted: 2017-01-11
• Last Update Posted: 2017-01-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 516

Inclusion Criteria

• Females are not pregnant or lactating
• Subjects meet DSM-IV criteria for opiate dependence, are medically and psychiatrically stable, and do not have a current history of benzodiazepine dependence abuse, dependence, or treatment

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Opiate abstinence

Trial Locations

Locations (11)

Hartford Dispensary; 🇺🇸 Hartford, Connecticut, United States

Connecticut Counseling Centers; 🇺🇸 Waterbury, Connecticut, United States

LI Jewish Health System; 🇺🇸 Glen Oaks, New York, United States

Coastal Horizons Center, Inc.; 🇺🇸 Wilmington, North Carolina, United States

Norfolk CSB; 🇺🇸 Norfolk, Virginia, United States

New York VA Medical Center; 🇺🇸 New York, New York, United States

South Light-Wakeview Clinic; 🇺🇸 Raleigh, North Carolina, United States

Providence Behavioral Health Services; 🇺🇸 Everett, Washington, United States

Addiction Research & Treatment Services (ARTS); 🇺🇸 Denver, Colorado, United States

Denver Health & Hospitals Authority; 🇺🇸 Denver, Colorado, United States

CODA; 🇺🇸 Portland, Oregon, United States